Videos de Experimentos Relacionados
Intervenciones de autogestión para enfermedades crónicas.
Stanton Newman1, Liz Steed, Kathleen Mulligan
1Unit of Health Psychology, Centre for Behavioural and Social Sciences in Medicine, University College London, London, UK. s.newman@ucl.ac.uk
Lancet (London, England)
|October 27, 2004
Resumen
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Working With School-Aged Children With Neurodisability and Oropharyngeal Dysphagia Who Require Mealtime Assistance: A Survey of Speech and Language Therapists' Clinical Practice.
International journal of language & communication disorders·2026
Same author
Long-term risk of depression in lung, colon, breast, and prostate cancer: a 25-year nationwide comparative study.
BMC cancer·2026
Same author
IMPlementing IMProved Asthma self-management as RouTine (IMP2ART) in UK primary care: An internal pilot for a cluster randomised controlled trial.
PloS one·2026
Same author
Barriers and enablers to shared decision-making in assessment and management of risk: A qualitative interview study with people using mental health services.
PLOS mental health·2026
Same author
Mealtime interventions for carers of school-aged children who have oropharyngeal dysphagia: A systematic review.
International journal of speech-language pathology·2026
Same author
Applying a cognitive behavioural approach in COPD: views of respiratory professionals.
ERJ open research·2025
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026